Denali Therapeutics

IPO

Transforming Life

Public · South San Francisco, United States · Founded 2015 · $1.3B raised

Employees
201–500
Founded
2015
Business Model
B2B
Total Funding
$1.3B
Last Round
$200.0M Venture RoundDec 2025
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Denali Therapeutics is a clinical-stage biotechnology company that invented the TransportVehicle™ platform, enabling biotherapeutics to cross the blood-brain barrier and treat neurodegenerative, lysosomal storage, and other serious diseases. With a clinically validated delivery platform, Denali is advancing a broad pipeline of investigational medicines in collaboration with partners including Biogen and Takeda.

Summary

Denali Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $1.3B in total across 5 rounds, most recently a $200.0M Venture Round in Dec 2025. Investors include Royalty Pharma, Baillie Gifford and Redmile Group.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundVenture RoundDec 2025
$200.0M

Sign up to see all 7 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Denali Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/denali-therapeutics"><img src="https://indexed.vc/api/badge/company/denali-therapeutics" alt="Denali Therapeutics on Indexed.vc" width="260" height="76" /></a>